Given that TRIM24 functions as a transcriptional co‐activator in breast cancer, prostate cancer, and GBM,[18, 20, 22] we reasoned that TRIM24 activated these pathways by regulating the transcriptional activation of multiple regulators in these pathways. Here, TRIM24 is linked to breast carcinoma.